Lavo Life Sciences
PrivateLast Round
Grant
Jul 15, 2025
Total Funding Raised
$775,000
Company Overview
Lavo Life Sciences operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Grant round in September 2023.
Lavo Life Sciences is a biotechnology company that provides an AI-accelerated platform for drug development, specializing in crystal structure prediction for small molecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lavo Life Sciences Comparables
Compare Lavo Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioSimulytics | 89% | |
| Simplexity Simulations LLC | 82% | |
| Genesis Molecular AI | 76% |
For institutional investors. Book with your work email.
Lavo Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 15, 2025 | ||||
| Grant | Sep 15, 2023 | ||||
| Accelerator | Apr 5, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lavo Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BBQ Capital | Accelerator |
| Eastlink Capital | Accelerator |
| Gershon Capital | Accelerator |
| Y Combinator | Accelerator |
| Undeterred Capital | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2025
$1.2M grant awarded by the National Science Foundation
- Jan 21, 2025
Launched the Crystal Console for small molecule crystal data.
For institutional investors. Book with your work email.
Lavo Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lavo Life Sciences's valuation, stock price, and market status.
Is Lavo Life Sciences a public or private company?
Lavo Life Sciences is a private company.
What is the current stock price of Lavo Life Sciences?
Lavo Life Sciences is a private company, so its shares have no public market price. Caplight tracks Lavo Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lavo Life Sciences worth (valuation)?
Valuation information for Lavo Life Sciences is not publicly available.
Can I buy Lavo Life Sciences stock?
Lavo Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lavo Life Sciences's last funding round?
Lavo Life Sciences's most recent funding round was Grant on July 15, 2025.
Who are the main investors in Lavo Life Sciences?
Key investors in Lavo Life Sciences include Y Combinator.
Will Lavo Life Sciences IPO soon?
No public IPO plans have been announced for Lavo Life Sciences.
How can I track Lavo Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Lavo Life Sciences's shares on secondary markets.